Celldex Therapeutics
CLDX
CLDX
85 hedge funds and large institutions have $11.3M invested in Celldex Therapeutics in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
51% less capital invested
Capital invested by funds: $23.2M → $11.3M (-$11.9M)
Holders
85
Holding in Top 10
2
Calls
$13K
Puts
–
Top Buyers
| 1 | +$424K | |
| 2 | +$403K | |
| 3 | +$94.1K | |
| 4 |
SWP
Stratos Wealth Partners
Beachwood,
Ohio
|
+$78.6K |
| 5 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
+$77.6K |
Top Sellers
| 1 | -$633K | |
| 2 | -$474K | |
| 3 | -$347K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$233K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$158K |